Clinical Trial Update: Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial studying whether adding Olaparib to radiation therapy improves outcomes for inflammatory breast cancer; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Breast Cancer

Drugs mentioned

• Olaparib (Olaparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Inflammatory Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING